Journal ArticleOPEN ACCESS

Transdermal physostigmine—absence of effect on topographic brain mapping

Behavioural Neurology (1993) 6(1) 33-35
DOI: 10.1155/1993/892685
0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD. © 1993 Rapid Communications of Oxford Ltd.

Author supplied keywords

Cite

CITATION STYLE

APA

Neufeld, M. Y., Mawassi, F., Levy, A., Treves, T. A., & Korczyn, A. D. (1993). Transdermal physostigmine—absence of effect on topographic brain mapping. Behavioural Neurology, 6(1), 33–35. https://doi.org/10.1155/1993/892685

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free